Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQT7Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,787
Award facts
- Contract value 100% obligated
- $57,787.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,787.20 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of 100 mg vials of Enhertu, an oncology pharmaceutical product. This is a firm fixed-price contract with an ultimate completion date of January 29, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor that plays a critical role in the federal medical supply chain, particularly for Defense Health Agency and military treatment facilities. The company maintains an extensive portfolio of pharmaceutical deliveries through the DLA, covering medications across multiple therapeutic domains including oncology, specialty pharmaceuticals, and generic drugs. As a subsidiary of Cencora, Inc., AmerisourceBergen leverages its parent company's established infrastructure and $999,999,999.00 IDC to efficiently fulfill government contracts for essential pharmaceutical commodities required by federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQT7Z?
SPE2DR26FQT7Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FQT7Z worth?
The government has obligated $57,787 on SPE2DR26FQT7Z.
Is contract SPE2DR26FQT7Z an order under another contract?
Yes. SPE2DR26FQT7Z is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT7Z competed?
The extent of competition for SPE2DR26FQT7Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award